Imidazole → 3-Fluoro-5-(1H-imidazol-1-yl)benzoic Acid

HRID 2216756Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2216756
Br[C:2]1[CH:7]=[C:6](F)[CH:5]=[C:4]([F:9])[CH:3]=1.[NH:10]1[CH:14]=[CH:13][N:12]=[CH:11]1.[C:15]([O-])([O-:17])=[O:16].[K+].[K+].O>CN(C=O)C>[F:9][C:4]1[CH:5]=[C:6]([CH:7]=[C:2]([N:10]2[CH:14]=[CH:13][N:12]=[CH:11]2)[CH:3]=1)[C:15]([OH:17])=[O:16]

Komponenten

6

Versuchsvorschrift

1-Bromo-3,5-difluorobenzene (1.00 g, 5.18 mmol) was dissolved in anhydrous DMF (10 mL). The solution was chilled in an ice bath. Imidazole (0.36 g, 5.18 mmol) and K2CO3 (0.72 g, 5.18 mmol) were added. The reaction mixture was stirred at room temperature for 16 hours, and at 80° C. for 0.24 hours. The reaction mixture was poured into water (100 mL) and extracted with EtOAc. The organic phase was washed with brine, dried (MgSO4), filtered, and concentrated. The intermediate 3-Fluoro-5-Bromo-(1H-imidazol-1-yl)-benzene was used directly in the next step. Using the standard cyanation procedure, 3-Fluoro-5-cyano-(1H-imidazol-1-yl)-benzene was prepared as a colourless solid. The crude product was used directly in the next step. Using the standard saponification procedure, the title compound was prepared as a colourless solid. The crude product was used directly in the next step.

Aufarbeitung

  1. temperatureThe solution was chilled in an ice bath
  2. waitat 80° C. for 0.24 hours
  3. extractionextracted with EtOAc
  4. washThe organic phase was washed with brine
  5. dry with materialdried (MgSO4)
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customwas prepared as a colourless solid

Quellen und Nachweise

ORD-Eintrag
ord-f54e3176518b481f9d755469a97d596f
Quelldatensatz
uspto-grants-2006_09
Patentnummer
US07112595B2

Notizen zur Reaktion

Wird geladen…